FDA issued a Warning Letter to Boehringer Ingelheim Pharma GMBH & Co on 5/6/2013 for a previous inspection.
483 Boehringer Ingelheim Pharma Gmbh & Co Kg Jul 2018

483 Boehringer Ingelheim Pharma Gmbh & Co Kg Jul 2018

Zhong Li FDA, Michael Shanks FDA$119.00 - Available Now

FDA investigators audited the Boehringer Ingelheim Pharma Gmbh & Co Kg - Biberach an der Ris, Germany facility and issued inspectional observations (via FDA 483) on 10 Jul 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 10 Jul 2018
  • Location: Biberach an der Ris, Germany
  • FEI: 3002806518
Add To Cart